 Efficacy tolerability topical terbinafine treatment tinea cruris Thirty men clinical mycologic evidence tinea cruris double-blind trial terbinafine cream cream vehicle placebo Patients test medications affected area weeks Therapeutic response evaluable patients week treatment follow-up visit weeks therapy visit terbinafine effective cream vehicle reduction signs symptoms infection conversion culture microscopy findings negative normal end treatment therapy effective terbinafine-treated patients placebo-treated patients follow-up examination efficacy rates terbinafine treatment group placebo group difference borderline statistical significance Possible reasons result incidence chronic disease terbinafine group large number patients delayed exclusions negative initial culture dermatophytes side effects significant alterations laboratory hematologic tests treatment group